199 related articles for article (PubMed ID: 33880574)
21. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
[TBL] [Abstract][Full Text] [Related]
22. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
23. Circ_0000388 Exerts Oncogenic Function in Cervical Cancer Cells by Regulating miR-337-3p/
Meng QH; Li Y; Kong C; Gao XM; Jiang XJ
Cancer Biother Radiopharm; 2021 Feb; 36(1):58-69. PubMed ID: 32119786
[No Abstract] [Full Text] [Related]
24. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
25. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W
Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118
[TBL] [Abstract][Full Text] [Related]
26. AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
Gan Q; Huang X; Zhao W; Liu H; Xu Y; Zhang X; Cheng J; Chen R
BMC Cancer; 2023 Apr; 23(1):364. PubMed ID: 37081411
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
[TBL] [Abstract][Full Text] [Related]
28. Long Intervening Noncoding 00467 RNA Contributes to Tumorigenesis by Acting as a Competing Endogenous RNA against miR-107 in Cervical Cancer Cells.
Li GC; Xin L; Wang YS; Chen Y
Am J Pathol; 2019 Nov; 189(11):2293-2310. PubMed ID: 31640853
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition.
Sun R; Qin C; Jiang B; Fang S; Pan X; Peng L; Liu Z; Li W; Li Y; Li G
Mol Biosyst; 2016 Mar; 12(3):952-62. PubMed ID: 26798987
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
Zou C; Fan J; He M; Xu Y; Wang K; Cai Y; Li M
Exp Cell Res; 2019 May; 378(2):139-148. PubMed ID: 30826396
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis.
Zhang J; Zhou M; Zhao X; Wang G; Li J
Pathol Res Pract; 2020 Aug; 216(8):152994. PubMed ID: 32402537
[TBL] [Abstract][Full Text] [Related]
32. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p.
Lin L; Xin B; Jiang T; Wang XL; Yang H; Shi TM
Mol Cell Biochem; 2020 Dec; 475(1-2):1-13. PubMed ID: 32740791
[TBL] [Abstract][Full Text] [Related]
34. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑130a‑3p promotes the proliferation and inhibits the apoptosis of cervical cancer cells via negative regulation of RUNX3.
Wang M; Wang X; Liu W
Mol Med Rep; 2020 Oct; 22(4):2990-3000. PubMed ID: 32945424
[TBL] [Abstract][Full Text] [Related]
36. FTO-stabilized lncRNA HOXC13-AS epigenetically upregulated FZD6 and activated Wnt/β-catenin signaling to drive cervical cancer proliferation, invasion, and EMT.
Wang T; Li W; Ye B; Zhang S; Lei X; Zhang D
J BUON; 2021; 26(4):1279-1291. PubMed ID: 34564982
[TBL] [Abstract][Full Text] [Related]
37. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833
[TBL] [Abstract][Full Text] [Related]
38. LINC00641 hinders the progression of cervical cancer by targeting miR-378a-3p/CPEB3.
Zhang Y; Yu R; Li L
J Gene Med; 2020 Sep; 22(9):e3212. PubMed ID: 32367630
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.
Zhang F; Zhou Q
Mol Med Rep; 2018 Dec; 18(6):4886-4894. PubMed ID: 30272359
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
Dai SG; Guo LL; Xia X; Pan Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):486-495. PubMed ID: 30720155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
